减持计划详情 翁康拟在2025年10月16日至2026年1月15日期间，通过大宗交易方式减持不超过521.425万股，即不超过 其持有公司股份总数的25%，不超过公司总股本的1.7024%；以集中竞价方式减持不超过306.2827万 股，即不超过其持有公司股份总数的25%且不超过公司总股本的1%。两种方式合计不超过521.425万 股。若减持计划期间公司有送股、资本公积金转增股本等股份变动事项，拟减持股份数量将相应调整。 吴镝拟在同一时间段内，通过大宗交易、集中竞价交易减持不超过1.425万股，即不超过其持有公司股 份总数的25%，不超过公司总股本的0.0047%。若减持计划期间公司有送股、资本公积金转增股本等股 份变动事项，拟减持股份数量也将相应调整。 登录新浪财经APP 搜索【信披】查看更多考评等级 9月17日，苏州麦迪斯顿医疗科技股份有限公司（以下简称"麦迪科技"）发布股东减持股份计划公告， 股东翁康、吴镝因个人资金安排，拟在公告十五个交易日后的三个月内减持公司股份。 减持主体情况 截至本次减持计划实施前，翁康持有麦迪科技2085.7003万股，占公司股本总数的6.8097%，股份来源于 IPO前取得。 ...

人民财讯9月16日电，麦迪科技（603990）9月16日晚间公告，公司股东翁康持有公司6.8097%股份。股 东吴镝持有公司0.0186%股份。翁康拟合计减持公司不超过521.43万股股份，即不超过公司总股本的 1.7%，吴镝拟以大宗交易、集中竞价交易择机减持其所持公司股份不超过1.43万股，即不超过其持有公 司股份总数的25%，不超过公司总股本的0.0047%。 ...

证券代码：603990 证券简称：麦迪科技 公告编号：2025-061 苏州麦迪斯顿医疗科技股份有限公司 重要内容提示： 大股东及董监高持股的基本情况 截至本次减持计划实施之前，苏州麦迪斯顿医疗科技股份有限公司（以下简 称"公司"）股东翁康先生持有公司股份 20,857,003 股，占公司股本总数的 6.8097%。吴镝先生持有公司股份 57,000 股，占公司股本总数的 0.0186%。 减持计划的主要内容 翁康先生拟在本计划公告十五个交易日后的三个月内，以大宗交易方式择机 减持其所持公司股份不超过 5,214,250 股，即不超过其持有公司股份总数的 25%， 不超过公司总股本的 1.7024%；以集中竞价方式减持其所持公司股份不超过 3,062,827 股，即不超过其持有公司股份总数的 25%且不超过公司总股本的 1%。 两种方式合计不超过 5,214,250 股。若减持计划期间公司有送股、资本公积金转 增股本等股份变动事项，本次拟减持股份数量将相应进行调整。 吴镝先生拟在本计划公告十五个交易日后的三个月内，以大宗交易、集中竞 价交易择机减持其所持公司股份不超过 14,250 股，即不超过其持有公司股份 ...

Group 1 - The core point of the article is that the shareholder, Weng Kang, plans to reduce his holdings in Madi Technology by up to 5.2142 million shares, which represents 1.7% of the company's total share capital [1] - The reduction will occur within three months after the announcement and will include methods such as block trading and centralized bidding, with a maximum of 5.2142 million shares and 3.0628 million shares respectively [1] - Another shareholder, Wu Di, also plans to reduce his holdings by up to 14,300 shares, which is 0.0047% of the company's total share capital, within the same timeframe [1] Group 2 - The implementation of the reduction plans is subject to market conditions and the shareholders' financial arrangements, indicating a level of uncertainty [1]

Core Viewpoint - The announcement from MediTech (603990.SH) indicates that shareholders are planning to reduce their holdings, which may impact the stock's performance in the near term [1] Shareholder Reduction Details - Shareholder Weng Kang intends to reduce his holdings by up to 5,214,250 shares, representing approximately 1.7024% of the company's total share capital [1] - Shareholder Wu Di plans to reduce his holdings by up to 14,250 shares, which accounts for about 0.0047% of the company's total share capital [1] - The reduction period is set from October 16, 2025, to January 15, 2026 [1] - The reason for the reduction is stated as personal financial arrangements [1]

Core Viewpoint - The major shareholders of MediTech plan to reduce their holdings starting from October 16, 2025, through block trades and centralized bidding, indicating potential changes in ownership structure and liquidity concerns [1] Shareholder Reduction Plans - Shareholder Weng Kang intends to reduce holdings by up to 5.21 million shares through block trades, representing 1.70% of the total share capital [1] - Additionally, Weng Kang plans to sell up to 3.06 million shares via centralized bidding, accounting for 1% of the total share capital [1] - Board member Wu Di also plans to reduce holdings by up to 14,300 shares through block trades or centralized bidding, which is 0.0047% of the total share capital [1] Source of Shares and Reasons for Reduction - The shares to be reduced by both shareholders were acquired prior to the IPO and through centralized bidding transactions [1] - The reason for the reduction is stated as personal financial arrangements for both shareholders [1] Implementation Uncertainty - The implementation of the reduction plan is noted to have uncertainties, which may affect the timing and execution of the share sales [1]

吴镝先生拟在本计划公告十五个交易日后的三个月内，以大宗交易、集中竞价交易择机减持其所持公司 股份不超过14,250股，即不超过其持有公司股份总数的25%，不超过公司总股本的0.0047%。 格隆汇9月16日丨麦迪科技(603990.SH)公布，翁康先生拟在本计划公告十五个交易日后的三个月内，以 大宗交易方式择机减持其所持公司股份不超过521.43万股，即不超过其持有公司股份总数的25%，不超 过公司总股本的1.7024%；以集中竞价方式减持其所持公司股份不超过306.28万股，即不超过其持有公 司股份总数的25%且不超过公司总股本的1%。两种方式合计不超过521.44万股。 ...

Core Viewpoint - The announcement from MediTech (603990.SH) indicates that major shareholders plan to reduce their holdings through block trades and centralized bidding, which may impact the stock's liquidity and market perception [1] Summary by Categories Shareholder Reduction Plans - Shareholder Mr. Weng Kang intends to reduce his holdings by up to 5,214,250 shares within three months after the announcement, representing 25% of his total holdings and 1.7024% of the company's total share capital [1] - Mr. Wu Di plans to reduce his holdings by up to 14,250 shares within the same timeframe, which is also 25% of his total holdings and 0.0047% of the company's total share capital [1] Trading Methods - The reduction by Mr. Weng will occur through block trades and centralized bidding, with a maximum of 3,062,827 shares to be sold via centralized bidding, which is 1% of the company's total share capital [1] - The combined total reduction for both shareholders will not exceed 5,214,250 shares [1]

吴镝先生拟在本计划公告十五个交易日后的三个月内，以大宗交易、集中竞价交易择机减持其所持公司 股份不超过14,250股，即不超过其持有公司股份总数的25%，不超过公司总股本的0.0047%。 麦迪科技（603990）(603990.SH)发布公告，股东翁康先生拟在本计划公告十五个交易日后的三个月 内，以大宗交易方式择机减持其所持公司股份不超过5,214,250股，即不超过其持有公司股份总数的 25%，不超过公司总股本的1.7024%;以集中竞价方式减持其所持公司股份不超过3,062,827股，即不超过 其持有公司股份总数的25%且不超过公司总股本的1%。两种方式合计不超过5,214,250股。 ...

Core Viewpoint - The announcement reveals that major shareholders of MediTech plan to reduce their holdings, indicating potential changes in ownership structure and market sentiment [1] Shareholder Reduction Plans - Shareholder Weng Kang intends to reduce his holdings by up to 5.2142 million shares, which represents no more than 1.7% of the company's total share capital [1] - The reduction will be executed through block trades and centralized bidding, with a maximum of 5.2142 million shares and 3.0628 million shares respectively [1] - Another shareholder, Wu Di, plans to reduce his holdings by up to 14,300 shares, accounting for no more than 0.0047% of the company's total share capital [1] - The implementation of these reduction plans is subject to market conditions and personal financial arrangements, indicating uncertainty [1]